BUZZ-Biotech firm Protara tumbles on planned $75 mln equity raise

Reuters12-05 06:15
BUZZ-Biotech firm Protara tumbles on planned $75 mln equity raise

** Protara Therapeutics' TARA.O shares down 12% after hours to $6.05 as co seeks equity

** Co commences $75 mln offering comprised of stock and pre-funded warrants

** It intends to use net offering proceeds to fund clinical development of its cell therapy, TARA-002, and development of other clinical programs

** Co developing TARA-002 in non-muscle invasive bladder cancer (NMIBC) and in lymphatic malformations (LMs), rare, non-malignant cysts of the lymphatic vascular system that primarily form in the head and neck region of children

** With ~38.6 mln shares outstanding, New York City-based TARA has ~$265 mln market cap

** JP Morgan, TD Cowen and Piper Sandler are joint bookrunners for offering

** TARA shares on Thurs closed up 1% at $6.87. Stock has gained 58% QTD, putting it up 30% YTD

** All 6 analysts are bullish on TARA; median PT is $25, per LSEG data

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment